Variations in the clinical practice of physicians managing Takayasu arteritis: a nationwide survey (original) (raw)
Disease-modifying anti-rheumatic drugs for the management of Takayasu arteritis—a systematic review and meta-analysis
aman sharma
Clinical Rheumatology, 2021
View PDFchevron_right
Refractory Case of Takayasu Arteritis in a Young Woman: A Clinical Challenge
Salman Mansoor
Cureus, 2016
View PDFchevron_right
The Journal of Rheumatology Volume 30, no. 8 outcome in active Takayasu's arteritis. Role of immunosuppressive therapy on clinical, immunological, and angiographic
Nakul Sinha
2000
View PDFchevron_right
Takayasu arteritis: assessment of response to medical therapy based on clinical activity criteria and imaging techniques
Henrique Mariz
Rheumatology International, 2010
View PDFchevron_right
Challenges with Takayasu's arteritis: A case study
Dezare Strider
Journal of Vascular Nursing, 1996
View PDFchevron_right
Long-term outcome of 251 patients with Takayasu arteritis on combination immunosuppressant therapy: Single centre experience from a large tertiary care teaching hospital in Southern India
George Joseph
Seminars in arthritis and rheumatism, 2017
View PDFchevron_right
Management of Takayasu arteritis: a systematic review
G. Keser
Rheumatology, 2014
View PDFchevron_right
SAT0270 TOCILIZUMAB in Refractory Takayasu Arteritis. Open-Label National Multicenter Study of 53 Patients of Clinical Practice
Roser Solans
Annals of the Rheumatic Diseases
View PDFchevron_right
Recent advances in Takayasu arteritis
Hajime Yoshifuji
International Journal of Rheumatic Diseases, 2014
View PDFchevron_right
Effectiveness and safety of adalimumab compared with leflunomide in patients with Takayasu arteritis: a retrospective cohort study
Faustino Peron
RMD open, 2024
View PDFchevron_right
Tocilizumab in refractory Caucasian Takayasu’s arteritis: a multicenter study of 54 patients and literature review
Paloma Vela
Therapeutic Advances in Musculoskeletal Disease
View PDFchevron_right
Is Takayasu's arteritis more severe in children?
Selcan Demir
Clinical and Experimental Rheumatology
View PDFchevron_right
Role of immunosuppressive therapy on clinical, immunological, and angiographic outcome in active Takayasu's arteritis
Nakul Sinha
The Journal of rheumatology, 2003
View PDFchevron_right
Takayasu's arteritis: A study of 104 Italian patients
Arrigo Schieppati
Arthritis and Rheumatism, 2005
View PDFchevron_right
Efficacy and safety of tocilizumab in treatment of Takayasu arteritis: A systematic review of randomized controlled trials
Ashish Mathew
Modern Rheumatology, 2020
View PDFchevron_right
Successful treatment of Takayasu arteritis with rituximab as a first-line immunosuppressant
Ursula Bond
BMJ case reports, 2017
View PDFchevron_right
Takayasu arteritis in childhood: retrospective experience from a tertiary referral centre in the UK
Pavla Dolezalova
Arthritis Research & Therapy, 2015
View PDFchevron_right
Efficacy of Biological-Targeted Treatments in Takayasu Arteritis: Multicenter Retrospective Study of 49 Patients
Sébastien Abad
Circulation, 2015
View PDFchevron_right
Assessment of disease activity and progression in Takayasu's arteritis with Disease Extent Index-Takayasu
Nurullah Akkoc
Rheumatology, 2010
View PDFchevron_right
AB0366 TOCILIZUMAB for Takayasu Arteritis: Multicenter Study of 54 White Patients
Roser Solans
Annals of the Rheumatic Diseases, 2021
View PDFchevron_right
Takayasu's arteritis: results of a university hospital of 45 patients in Turkey
Ahmet Mesut Onat
International Journal of Cardiology, 2004
View PDFchevron_right
Clinical characteristics and long-term outcome of Takayasu arteritis in Iran: a multicentre study
Alireza Khabbazi
Turkish Journal of Medical Sciences, 2020
View PDFchevron_right
Presentation and Disease Course of Childhood‐Onset Versus Adult‐Onset Takayasu Arteritis
Roaa Alsolaimani
Arthritis & rheumatology, 2018
View PDFchevron_right
Takayasu arteritis: burnt out or not?
Richard Travers
APLAR Journal of Rheumatology, 2007
View PDFchevron_right
Overview of late outcome of medical and surgical treatment for Takayasu arteritis
Soichiro Kitamura
Circulation, 2008
View PDFchevron_right
Outcomes of patients with takayasu arteritis treated with infliximab
Carlos Cañas
The Journal of rheumatology, 2013
View PDFchevron_right
Effects of glucocorticoids and tumor necrosis factor-alpha inhibitors on both clinical and molecular parameters in patients with Takayasu arteritis
Luca Gallelli
Journal of pharmacology & pharmacotherapeutics, 2014
View PDFchevron_right
The Course and Outcomes of COVID-19 in Patients with Takayasu Arteritis: Case Series of 15 Patients from a Tertiary Single Center
seda kutluğ ağaçkıran
Rheumatology Quarterly
View PDFchevron_right
Successful multitarget therapy using mizoribine and tacrolimus for refractory Takayasu arteritis
Akihiro Yachie
Rheumatology, 2014
View PDFchevron_right
AB0573 The Disease Associations of Takayasu's Arteritis
Sinem Esatoglu
Annals of the Rheumatic Diseases, 2016
View PDFchevron_right
French recommendations for the management of Takayasu’s arteritis
Olivier Espitia
Orphanet Journal of Rare Diseases, 2021
View PDFchevron_right
Childhood-onset Takayasu arteritis: an update
Ashish Mathew
International Journal of Rheumatic Diseases, 2015
View PDFchevron_right